TY  - JOUR
AU  - Toral, Marta
AU  - Robles-Vera, Iñaki
AU  - Romero, Miguel
AU  - de la Visitacion, Nestor
AU  - Sanchez, Manuel
AU  - O'Valle, Francisco
AU  - Rodriguez-Nogales, Alba
AU  - Galvez, Julio
AU  - Duarte, Juan
AU  - Jimenez, Rosario
PY  - 2019
DO  - 10.1096/fj.201900545RR
UR  - http://hdl.handle.net/10668/14085
T2  - FASEB journal : official publication of the Federation of American Societies for Experimental Biology
AB  - The aim of the present study was to examine whether the immune-modulatory bacteria Lactobacillus fermentum CECT5716 (LC40) ameliorates disease activity and cardiovascular complications in a female mouse model of lupus. Eighteen-week-old NZBWF1...
LA  - en
PB  - John Wiley & Sons, Inc.
KW  - endothelial dysfunction
KW  - gut dysbiosis
KW  - hypertension
KW  - oxidative stress
KW  - probiotics
KW  - Acetylcholine
KW  - Animals
KW  - Aorta
KW  - Bacterial Translocation
KW  - Bifidobacterium
KW  - Cytokines
KW  - Disease Models, Animal
KW  - Dysbiosis
KW  - Endotoxemia
KW  - Female
KW  - Gastrointestinal Microbiome
KW  - Hypertension
KW  - Kidney
KW  - Limosilactobacillus fermentum
KW  - Lupus Erythematosus, Systemic
KW  - Lupus Nephritis
KW  - Mice
KW  - Mice, Inbred NZB
KW  - Myocardium
KW  - Organ Size
KW  - Probiotics
KW  - Signal Transduction
KW  - T-Lymphocytes
KW  - Vascular Diseases
TI  - Lactobacillus fermentum CECT5716: a novel alternative for the prevention of vascular disorders in a mouse model of systemic lupus erythematosus.
TY  - research article
VL  - 33
ER  -